Titre : Traitement par apport liquidien

Traitement par apport liquidien : Questions médicales fréquentes

Termes MeSH sélectionnés :

Disability Evaluation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Traitement par apport liquidien : Questions médicales les plus fréquentes", "headline": "Traitement par apport liquidien : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Traitement par apport liquidien : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Traitement par apport liquidien" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Traitement médicamenteux", "url": "https://questionsmedicales.fr/mesh/D004358", "about": { "@type": "MedicalCondition", "name": "Traitement médicamenteux", "code": { "@type": "MedicalCode", "code": "D004358", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.319" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypodermoclyse", "alternateName": "Hypodermoclysis", "url": "https://questionsmedicales.fr/mesh/D055103", "about": { "@type": "MedicalCondition", "name": "Hypodermoclyse", "code": { "@type": "MedicalCode", "code": "D055103", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.319.360.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Traitement par apport liquidien", "alternateName": "Fluid Therapy", "code": { "@type": "MedicalCode", "code": "D005440", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Robert G Hahn", "url": "https://questionsmedicales.fr/author/Robert%20G%20Hahn", "affiliation": { "@type": "Organization", "name": "Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Amy K Keir", "url": "https://questionsmedicales.fr/author/Amy%20K%20Keir", "affiliation": { "@type": "Organization", "name": "Department of Neonatal Medicine, Women's and Children's Hospital, North Adelaide, South Australia; SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, South Australia; Adelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, South Australia. Electronic address: amy.keir@adelaide.edu.au." } }, { "@type": "Person", "name": "Matthew W Semler", "url": "https://questionsmedicales.fr/author/Matthew%20W%20Semler", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University, Nashville, Tennessee, USA." } }, { "@type": "Person", "name": "Matthias Jacob", "url": "https://questionsmedicales.fr/author/Matthias%20Jacob", "affiliation": { "@type": "Organization", "name": "Department of Anesthesiology and Surgical Intensive Care, St. Elisabeth Hospital, Straubing, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36131595", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/13524585221114997" } }, { "@type": "ScholarlyArticle", "name": "[New assessment recommendations for disability in private accident insurance, part 4 : An interdisciplinary consensus approach-Disability outside the compensation scheme].", "datePublished": "2023-07-05", "url": "https://questionsmedicales.fr/article/37405507", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00113-023-01344-7" } }, { "@type": "ScholarlyArticle", "name": "Measuring disability in multiple sclerosis: the WHODAS 2.0.", "datePublished": "2023-08-17", "url": "https://questionsmedicales.fr/article/37589773", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11136-023-03470-6" } }, { "@type": "ScholarlyArticle", "name": "Handling of missing items in the Oswestry disability index and the neck disability index. A study from Swespine, the National Swedish spine register.", "datePublished": "2022-10-22", "url": "https://questionsmedicales.fr/article/36271985", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00586-022-07425-2" } }, { "@type": "ScholarlyArticle", "name": "The relationship between changes in pain intensity and functional disability in persistent disabling low back pain during a course of cognitive functional therapy.", "datePublished": "2024-10-03", "url": "https://questionsmedicales.fr/article/39361965", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1515/sjpain-2024-0040" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Traitement médicamenteux", "item": "https://questionsmedicales.fr/mesh/D004358" }, { "@type": "ListItem", "position": 4, "name": "Traitement par apport liquidien", "item": "https://questionsmedicales.fr/mesh/D005440" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Traitement par apport liquidien - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Traitement par apport liquidien", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Traitement par apport liquidien", "description": "Comment diagnostiquer une déshydratation ?\nQuels tests sont utilisés pour évaluer l'hydratation ?\nQuels signes indiquent un besoin de traitement liquidien ?\nComment évaluer l'équilibre électrolytique ?\nQuels sont les critères de gravité de la déshydratation ?", "url": "https://questionsmedicales.fr/mesh/D005440?mesh_terms=Disability+Evaluation&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Traitement par apport liquidien", "description": "Quels sont les symptômes de la déshydratation ?\nComment reconnaître une hyperhydratation ?\nQuels symptômes nécessitent une attention médicale ?\nQuels sont les signes de déséquilibre électrolytique ?\nComment la déshydratation affecte-t-elle la performance physique ?", "url": "https://questionsmedicales.fr/mesh/D005440?mesh_terms=Disability+Evaluation&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Traitement par apport liquidien", "description": "Comment prévenir la déshydratation ?\nQuels aliments aident à maintenir l'hydratation ?\nComment éviter l'hyperhydratation ?\nQuels conseils pour les sportifs en période de chaleur ?\nComment adapter l'hydratation en cas de maladie ?", "url": "https://questionsmedicales.fr/mesh/D005440?mesh_terms=Disability+Evaluation&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Traitement par apport liquidien", "description": "Quels types de fluides sont utilisés en thérapie liquidienne ?\nComment administrer des liquides par voie orale ?\nQuand utiliser une perfusion intraveineuse ?\nQuels sont les risques d'une surhydratation ?\nComment surveiller l'efficacité du traitement liquidien ?", "url": "https://questionsmedicales.fr/mesh/D005440?mesh_terms=Disability+Evaluation&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Traitement par apport liquidien", "description": "Quelles complications peuvent survenir avec une déshydratation sévère ?\nQuels sont les effets d'une surhydratation prolongée ?\nComment la déshydratation affecte-t-elle les organes ?\nQuels sont les risques d'une perfusion mal administrée ?\nQuelles sont les conséquences d'un traitement liquidien inapproprié ?", "url": "https://questionsmedicales.fr/mesh/D005440?mesh_terms=Disability+Evaluation&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Traitement par apport liquidien", "description": "Quels facteurs augmentent le risque de déshydratation ?\nComment les maladies affectent-elles l'hydratation ?\nQuel rôle joue l'exercice dans l'hydratation ?\nComment l'alimentation influence-t-elle l'hydratation ?\nQuels médicaments peuvent affecter l'hydratation ?", "url": "https://questionsmedicales.fr/mesh/D005440?mesh_terms=Disability+Evaluation&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déshydratation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation est diagnostiquée par des signes cliniques et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'hydratation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'analyse sanguine, l'urine et l'évaluation clinique des symptômes." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin de traitement liquidien ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent soif intense, sécheresse de la peau, fatigue et confusion." } }, { "@type": "Question", "name": "Comment évaluer l'équilibre électrolytique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'équilibre électrolytique est évalué par des tests sanguins mesurant les niveaux d'électrolytes." } }, { "@type": "Question", "name": "Quels sont les critères de gravité de la déshydratation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la perte de poids, la fréquence cardiaque et la pression artérielle." } }, { "@type": "Question", "name": "Quels sont les symptômes de la déshydratation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent soif, bouche sèche, fatigue, vertiges et urine foncée." } }, { "@type": "Question", "name": "Comment reconnaître une hyperhydratation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent œdème, hypertension, confusion et essoufflement." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une attention médicale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme confusion, convulsions ou perte de conscience nécessitent une urgence." } }, { "@type": "Question", "name": "Quels sont les signes de déséquilibre électrolytique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent crampes musculaires, fatigue, palpitations et confusion mentale." } }, { "@type": "Question", "name": "Comment la déshydratation affecte-t-elle la performance physique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une diminution de l'endurance, de la force et des temps de réaction." } }, { "@type": "Question", "name": "Comment prévenir la déshydratation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de boire régulièrement, surtout lors d'activités physiques ou par temps chaud." } }, { "@type": "Question", "name": "Quels aliments aident à maintenir l'hydratation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les fruits et légumes riches en eau, comme la pastèque et le concombre, sont bénéfiques." } }, { "@type": "Question", "name": "Comment éviter l'hyperhydratation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer trop de liquides en peu de temps, surtout lors d'activités intenses." } }, { "@type": "Question", "name": "Quels conseils pour les sportifs en période de chaleur ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les sportifs doivent s'hydrater avant, pendant et après l'exercice, en surveillant les signes de déshydratation." } }, { "@type": "Question", "name": "Comment adapter l'hydratation en cas de maladie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Augmentez l'apport liquidien en cas de fièvre, vomissements ou diarrhée pour prévenir la déshydratation." } }, { "@type": "Question", "name": "Quels types de fluides sont utilisés en thérapie liquidienne ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les fluides intraveineux, comme les solutions salines et glucosées, sont couramment utilisés." } }, { "@type": "Question", "name": "Comment administrer des liquides par voie orale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les liquides peuvent être administrés par gorgées fréquentes ou via des solutions de réhydratation." } }, { "@type": "Question", "name": "Quand utiliser une perfusion intraveineuse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une perfusion est utilisée en cas de déshydratation sévère ou lorsque l'administration orale est impossible." } }, { "@type": "Question", "name": "Quels sont les risques d'une surhydratation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent œdème pulmonaire, hypertension et déséquilibre électrolytique." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement liquidien ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est surveillée par l'évaluation des signes vitaux, de l'urine et des symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déshydratation sévère ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent insuffisance rénale, choc hypovolémique et troubles neurologiques." } }, { "@type": "Question", "name": "Quels sont les effets d'une surhydratation prolongée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une surhydratation prolongée peut entraîner des œdèmes, des troubles respiratoires et des déséquilibres électrolytiques." } }, { "@type": "Question", "name": "Comment la déshydratation affecte-t-elle les organes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des lésions rénales, des troubles cardiaques et des dysfonctionnements cérébraux." } }, { "@type": "Question", "name": "Quels sont les risques d'une perfusion mal administrée ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent infection, phlébite et déséquilibre électrolytique." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'un traitement liquidien inapproprié ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement inapproprié peut aggraver la déshydratation ou provoquer une surhydratation." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de déshydratation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, les maladies chroniques et les conditions climatiques extrêmes." } }, { "@type": "Question", "name": "Comment les maladies affectent-elles l'hydratation ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies, comme le diabète, augmentent la perte de liquides et le risque de déshydratation." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice dans l'hydratation ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice intense augmente la perte de liquides, nécessitant une hydratation adéquate." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle l'hydratation ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre en eau et en électrolytes peut augmenter le risque de déshydratation." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter l'hydratation ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains diurétiques et laxatifs peuvent augmenter le risque de déshydratation." } } ] } ] }

Sources (10000 au total)

Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.

Overall Disability Response Score (ODRS) is a composite endpoint including Expanded Disability Status Scale, Timed 25-foot Walk, and 9-Hole Peg Test, designed to quantify both disability improvement a... To assess the sensitivity and clinical meaningfulness of ODRS using natalizumab Phase 3 data sets (AFFIRM in relapsing-remitting MS and ASCEND in secondary progressive MS).... Differences in ODRS over 96 weeks, ODRS at Week 96, and slope of ODRS change per year between natalizumab and placebo groups were analyzed. Correlation between ODRS and changes in patient-reported out... The difference (95% confidence interval (CI)) in the ODRS over 96 weeks between natalizumab and placebo groups was 0.34 (0.21-0.46) in AFFIRM (... This analysis supports ODRS as a sensitive and potentially clinically meaningful disability outcome measure in MS....

[New assessment recommendations for disability in private accident insurance, part 4 : An interdisciplinary consensus approach-Disability outside the compensation scheme].

The following article is an element of a 4-part series on the presentation and discussion of new design recommendations for disability compensation in the private accident insurance. The introduction ...

Measuring disability in multiple sclerosis: the WHODAS 2.0.

Reliable measurement of disability in multiple sclerosis (MS) using a comprehensive, patient self-reported scale, such as the World Health Organization Disability Assessment Schedule (WHODAS) 2.0, wou... In the Trajectories of Outcome in Neurological Conditions-MS study, WHODAS 2.0 (WHODAS-36 items for working, WHODAS-32 items if not working, WHODAS-12 items short-form) was examined using Rasch analys... The 36- and 32-item parallel forms, and the cognitive and physical domains, showed reliability consistent with individual or group use. The 12-item short-form is valid for group use only. Interval lev... Disability in MS can be comprehensively measured at interval level by the WHODAS 2.0, and validly monitored over time. Routine use of this self-reported measure in clinical and research practice would...

Handling of missing items in the Oswestry disability index and the neck disability index. A study from Swespine, the National Swedish spine register.

The Oswestry Disability Index (ODI) and the Neck Disability Index (NDI) scoring algorithms used by the Swedish spine register (Swespine) until April 2022 handled missing items somewhat differently tha... Patients surgically treated for degenerative conditions of the lumbar or cervical spine between 2003-2019 (lumbar) and 2006-2019 (cervical) were identified in Swespine. Preoperative and 1-year postope... The preoperative as well as the 1-year postoperative ODI/NDI were approximately 1 unit out of 100 smaller for the Swespine algorithm, irrespective of adjustment model. The differences between preopera... The Swespine algorithms, used until April 2022, underestimated the ODI and NDI by approximately 1 out of 100 units compared with the original algorithms. In addition, there were no statistically signi...

The relationship between changes in pain intensity and functional disability in persistent disabling low back pain during a course of cognitive functional therapy.

Pain relief and reduced disability are both common treatment targets for persistent disabling low back pain (LBP). Cross-sectional studies show a moderate relationship between functional disability an... Self-reported measures of pain intensity and patient-specific functional disability were collected prior to each treatment session from 40 participants during a 12-week intervention period. Linear mix... Thirty-five participants had sufficient data for analysis. Using the linear mixed-model approach, there was evidence of a moderate and simultaneous association between pain intensity and functional di... Changes in pain intensity and functional disability were moderately related across the intervention. Visual inspection of graphs indicated a very close relationship in some individuals and a decouplin...

Disability and cognitive impairment are interdependent in primary antiphospholipid syndrome.

Cognitive impairment (CI) occurs at a high frequency in primary antiphospholipid syndrome (PAPS). Its psychosocial-related factors are of interest.... We aimed to determine disability and perceived stress and their correlation with CI in PAPS.... First study phase: a longitudinal study including patients with PAPS and paired controls for cardiovascular risk factors, age, and sex, determining CI with Montreal Cognitive Assessment (MoCA) and the... Sixty-three patients with PAPS and 60 controls were studied. In PAPS, age (range, 48.0 ± 13.5 years), thrombotic artery events (TAE) (44.4%), and stroke/TIA (42.8%) were found. Disability was document... Disability in PAPS and CI are interdependent. New treatment options and neurocognitive stimulation strategies are necessary to maintain functionality and prevent further cognitive dysfunction in PAPS ...

Functioning and Disability in Community-Living People with Perceived Cognitive Impairment or Dementia: A Mixed Methods Study using the World Health Organization Disability Assessment Schedule.

To explore how community-living people with perceived cognitive impairment or dementia and their next-of-kin perceive functioning and disability in major life domains.... Individual interviews guided by the World Health Organization Disability Assessment Schedule (WHODAS 2.0) were conducted with 26 people with perceived cognitive impairment or dementia (age range 38-87... A total of 38 of 47 (81%) established ICF categories corresponding to WHODAS items and 38 additional International Classification of Functioning, Disability, and Health (ICF) categories describing par... Interviews provided a comprehensive picture of participants' perceived activity limitations and participation restrictions in the life domains cognition, mobility, self-care, getting along, life activ...